ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $352,000 | +3100.0% | 10,661 | +3242.0% | 0.01% | – |
| Q2 2022 | $11,000 | -89.7% | 319 | -86.3% | 0.00% | -100.0% |
| Q1 2022 | $107,000 | +137.8% | 2,335 | +241.9% | 0.00% | +100.0% |
| Q1 2021 | $45,000 | +80.0% | 683 | +108.2% | 0.00% | +100.0% |
| Q4 2020 | $25,000 | +257.1% | 328 | +192.9% | 0.00% | -50.0% |
| Q4 2019 | $7,000 | – | 112 | +1144.4% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 9 | -80.4% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 46 | -4.2% | 0.00% | – |
| Q4 2018 | $1,000 | – | 48 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |